Sources | Names Used |
---|---|
CTRPv2 | decitabine:carboplatin (1:1 mol/mol) |
PharmacoGx | decitabine:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NOL9 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |
mRNA | MFN1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |
mRNA | HABP4 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.003 |
mRNA | DNASE1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
mRNA | TAS2R3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |
mRNA | KATNB1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |
mRNA | PRRT3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |
mRNA | FOSL2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.003 |
mRNA | C11orf84 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |
mRNA | PHLPP1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |